About Eclat Pharmaceuticals
Eclat Pharmaceuticals is a Healthcare company based in Missouri City (United States) founded in 2010, and was acquired by Avadel Pharmaceuticals in March 2012. Gasket sheets and sealing solutions are manufactured for industrial applications. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Manufacturer of gasket sheets and sealing solutions. It provides a variety of gasket materials, including Tesnit, Doniflex, Grafilit, Doniflon, and Micalit sheets. The company also offers a range of gaskets, such as soft flat gaskets, semi-metallic gaskets, heat exchangers gaskets, metal gaskets, and PTFE-enveloped gaskets and machined products. Additional services include application engineering, training courses, and material selection assistance. A gasket calculation software is also available.
- Headquarters Missouri City, United States
- Stage Acquired
- SectorsHealthcare
- Website eclatpharma.com
- Social LinkedIn
- Acquired by Avadel Pharmaceuticals (Mar 2012)
- Investors
- Acquired byAvadel Pharmaceuticals
(Mar 2012)
Investors in Eclat Pharmaceuticals
Eclat Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Avadel Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Proprietary drug delivery technologies and narcolepsy treatments are developed. | 1990 | avadel.com | Dublin, Ireland |
Investor details for Eclat Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Eclat Pharmaceuticals
2 dated milestones of Eclat Pharmaceuticals across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Eclat Pharmaceuticals is founded.
- Exit Acquired by Avadel Pharmaceuticals.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Eclat Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eclat Pharmaceuticals
Eclat Pharmaceuticals was founded in 2010.
Eclat Pharmaceuticals is headquartered in Missouri City, United States. It is registered at Missouri City, Texas, United States.
Manufacturer of gasket sheets and sealing solutions. It provides a variety of gasket materials, including Tesnit, Doniflex, Grafilit, Doniflon, and Micalit sheets. The company also offers a range of gaskets, such as soft flat gaskets, semi-metallic gaskets, heat exchangers gaskets, metal gaskets, and PTFE-enveloped gaskets and machined products. Additional services include application engineering, training courses, and material selection assistance. A gasket calculation software is also available.
Eclat Pharmaceuticals has 1 investor. Key investors include Avadel Pharmaceuticals.
Yes. Eclat Pharmaceuticals was acquired by Avadel Pharmaceuticals in March 2012.